Piyush Durani, MD

Director, Global Oncology Clinical Development
Bristol Myers Squibb, United States

Presentation(s):

• 63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)

  Friday, March 24, 2023
  11:24 AM – 11:34 AM

  Disclosure information not submitted.